BIGG

Parkinson’s disease in adults

England. National Institute for Health and Care Excellence.

This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care....

Parkinson Disease/drug therapy, Parkinson Disease/diagnosis, Neuroprotective Agents/therapeutic use, Vitamin E/therapeutic use, Dopamine Agonists/therapeutic use, Monoamine Oxidase Inhibitors/therapeutic use, Parkinson Disease/therapy, Occupational Therapy, Levodopa/therapeutic use, Carbidopa/therapeutic use, Palliative Care

Fulltext

Non-alcoholic fatty liver disease (NAFLD): assessment and management

England. National Institute for Health and Care Excellence.

This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced li...

Non-alcoholic Fatty Liver Disease/therapy, Non-alcoholic Fatty Liver Disease/drug therapy, Non-alcoholic Fatty Liver Disease/diagnosis, Pioglitazone/therapeutic use, Vitamin E/therapeutic use, Liver Cirrhosis/prevention & control, Metabolic Syndrome/prevention & control

Fulltext

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

J. Gastroenterol; 50 (4), 2015

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a serious public health issue not only in Western countries but also in many Asian countries including Japan. Within the wide spectrum of NAFLD, nonal...

Non-alcoholic Fatty Liver Disease/drug therapy, Thiazolidinediones/therapeutic use, Vitamin E/therapeutic use, Bariatric Surgery, Liver Transplantation

Fulltext